Antibody characterization using novel ERLIC-MS/MS-based peptide mapping

References

• Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. MAbs. 2015;7:9–14. doi:10.4161/19420862.2015.989042.
   PubMed Web of Science ®Google Scholar
• Mullard A. 2016 FDA drug approvals. Nat Rev Drug Discov. 2017;16:73–76. doi:10.1038/nrd.2017.14.
   PubMed Web of Science ®Google Scholar
• Shepard HM, Phillips GL, Thanos CD, Feldmann M. Developments in therapy with monoclonal antibodies and related proteins. Clin Med (Lond). 2017;17:220–232. doi:10.7861/clinmedicine.17-3-220.
   PubMed Web of Science ®Google Scholar
• Hey A. History and practice: antibodies in infectious diseases. Microbiol Spectr. 2015;3:AID-0026–2014. doi:10.1128/microbiolspec.AID-0026-2014.
   PubMed Web of Science ®Google Scholar
• Novak JC, Lovett-Racke AE, Racke MK. Monoclonal antibody therapies and neurologic disorders. Arch Neurol. 2008;65:1162–1165. doi:10.1001/archneur.65.9.1162.
   PubMedGoogle Scholar
• Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol. 2014;32:992–1000. doi:10.1038/nbt.3040.
   PubMed Web of Science ®Google Scholar
• Liu H, Ponniah G, Zhang H-M, Nowak C, Neill A, Gonzalez-Lopez N, Patel R, Cheng G, Kita AZ, Andrien B. In vitro and in vivo modifications of recombinant and human IgG antibodies. MAbs. 2014;1145–1154. doi:10.4161/mabs.29883.
   PubMed Web of Science ®Google Scholar
• Struble E, Kirschbaum N, Liu J, Marszal E, Shapiro M. Protein Therapeutics. Topics in Medicinal Chemistry. Vol. 21. Cham: Springer. doi:10.1007/7355_2015_5005.
   Google Scholar
• Gramer MJ. Product quality considerations for mammalian cell culture process development and manufacturing. Adv Biochem Eng Biotechnol. 2014;139:123–166. doi:10.1007/10_2013_214.
   PubMed Web of Science ®Google Scholar
• Bongers J, Cummings JJ, Ebert MB, Federici MM, Gledhill L, Gulati D, Hilliard GM, Jones BH, Lee KR, Mozdzanowski J, et al. Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times?. J Pharm Biomed Anal. 2000;21:1099–1128.
   PubMed Web of Science ®Google Scholar
• Højrup P. Proteolytic peptide mapping. HPLC of Peptides and Proteins: Methods and Protocols. 2004;251:227–244.
   Google Scholar
• Gaza-Bulseco G, Li B, Bulseco A, Liu H. Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody. Anal Chem. 2008;80:9491–9498. doi:10.1021/ac801617u.
   PubMed Web of Science ®Google Scholar
• Ren D, Ratnaswamy G, Beierle J, Treuheit MJ, Brems DN, Bondarenko PV. Degradation products analysis of an Fc fusion protein using LC/MS methods. Int J Biol Macromol. 2009;44:81–85. doi:10.1016/j.ijbiomac.2008.10.006.
   PubMed Web of Science ®Google Scholar
• Alpert AJ. Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides. Anal Chem. 2008;80:62–76. doi:10.1021/ac070997p.
   PubMed Web of Science ®Google Scholar
• Alpert AJ, Hudecz O, Mechtler K. Anion-exchange chromatography of phosphopeptides: weak anion exchange versus strong anion exchange and anion-exchange chromatography versus electrostatic repulsion-hydrophilic interaction chromatography. Anal Chem. 2015;87:4704–4711. doi:10.1021/ac504420c.
   PubMed Web of Science ®Google Scholar
• Boichenko AP, Govorukhina N, Van Der Zee AG, Bischoff R. Multidimensional separation of tryptic peptides from human serum proteins using reversed-phase, strong cation exchange, weak anion exchange, and fused-core fluorinated stationary phases. J Sep Sci. 2013;36:3463–3470. doi:10.1002/jssc.201300750.
   PubMed Web of Science ®Google Scholar
• Rogers RS, Nightlinger NS, Livingston B, Campbell P, Bailey R, Balland A. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics. MAbs. 2015;7:881–890. doi:10.1080/19420862.2015.1069454.
   PubMed Web of Science ®Google Scholar
• Wang C, Yamniuk A, Dai J, Chen S, Stetsko P, Ditto N, Zhang Y. Investigation of a degradant in a biologics formulation buffer containing L-histidine. Pharm Res. 2015;32:2625–2635. doi:10.1007/s11095-015-1648-8.
   PubMed Web of Science ®Google Scholar
• Loroch S, Schommartz T, Brune W, Zahedi RP, Sickmann A. Multidimensional electrostatic repulsion–hydrophilic interaction chromatography (ERLIC) for quantitative analysis of the proteome and phosphoproteome in clinical and biomedical research. Biochimica Et Biophysica Acta (Bba)-Proteins and Proteomics. 2015;1854:460–468. doi:10.1016/j.bbapap.2015.01.006.
   PubMed Web of Science ®Google Scholar
• Hao P, Qian J, Dutta B, Cheow ESH, Sim KH, Meng W, Adav SS, Alpert A, Sze SK. Enhanced separation and characterization of deamidated peptides with RP-ERLIC-based multidimensional chromatography coupled with tandem mass spectrometry. J Proteome Res. 2012;11:1804–1811. doi:10.1021/pr201048c.
   PubMed Web of Science ®Google Scholar
• Hao P, Guo T, Li X, Adav SS, Yang J, Wei M, Sze SW. Novel application of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) in shotgun proteomics: comprehensive profiling of rat kidney proteome. J Proteome Res. 2010;9:3520–3526. doi:10.1021/pr100037h.
   PubMed Web of Science ®Google Scholar
• Serra A, Gallart-Palau X, Wei J, Sze SK. Characterization of glutamine deamidation by long-length electrostatic repulsion-hydrophilic interaction chromatography-tandem mass spectrometry (LERLIC-MS/MS) in shotgun proteomics. Anal Chem. 2016;88:10573–10582. doi:10.1021/acs.analchem.6b02688.
   PubMed Web of Science ®Google Scholar
• Alpert AJ, Petritis K, Kangas L, Smith RD, Mechtler K, Mitulovic G, Mohammed S, Heck AJR. Peptide orientation affects selectivity in ion-exchange chromatography. Anal Chem. 2010;82:5253–5259. doi:10.1021/ac100651k.
   PubMed Web of Science ®Google Scholar
• Michalski A, Damoc E, Hauschild J-P, Lange O, Wieghaus A, Makarov A, Nagaraj N, Cox J, Mann M, Horning S. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol Cell Proteomics. 2011;10:M111. 011015. doi:10.1074/mcp.M111.011015.
   PubMed Web of Science ®Google Scholar
• Krokhin OV, Anderson G, Spicer V, Sun L, Dovichi NJ. Predicting electrophoretic mobility of tryptic peptides for high-throughput CZE-MS analysis. Anal Chem. 2017;89:2000–2008. doi:10.1021/acs.analchem.6b04544.
   PubMed Web of Science ®Google Scholar
• Krokhin OV, Ezzati P, Spicer V. Peptide retention time prediction in hydrophilic interaction liquid chromatography: data collection methods and features of additive and sequence-specific models. Anal Chem. 2017;89:5526–5533. doi:10.1021/acs.analchem.7b00537.
   PubMed Web of Science ®Google Scholar
• Petritis K, Kangas LJ, Yan B, Monroe ME, Strittmatter EF, Qian WJ, Adkins JN, Moore RJ, Xu Y, Lipton MS, et al. Improved peptide elution time prediction for reversed-phase liquid chromatography-MS by incorporating peptide sequence information. Anal Chem. 2006;78:5026–5039. doi:10.1021/ac060143p.
   PubMed Web of Science ®Google Scholar
• Gilar M, Jaworski A, Olivova P, Gebler JC. Peptide retention prediction applied to proteomic data analysis. Rapid Commun Mass Spectrom. 2007;21:2813–2821. doi:10.1002/rcm.3150.
   PubMed Web of Science ®Google Scholar
• Liu YD, Goetze AM, Bass RB, Flynn GC. N-terminal glutamate to pyroglutamate conversion in vivo for human IgG2 antibodies. J Biol Chem. 2011;286:11211–11217. doi:10.1074/jbc.M110.185041.
   PubMed Web of Science ®Google Scholar
• Chelius D, Jing K, Lueras A, Rehder DS, Dillon TM, Vizel A, Rajan RS, Li T, Treuheit MJ, Bondarenko PV. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal Chem. 2006;78:2370–2376. doi:10.1021/ac051827k.
   PubMed Web of Science ®Google Scholar
• Pan H, Chen K, Chu L, Kinderman F, Apostol I, Huang G. Methionine oxidation in human IgG2 Fc decreases binding affinities to protein A and FcRn. Protein Sci. 2009;18:424–433. doi:10.1002/pro.45.
   PubMed Web of Science ®Google Scholar
• Guan Z, Yates NA, Bakhtiar R. Detection and characterization of methionine oxidation in peptides by collision-induced dissociation and electron capture dissociation. J Am Soc Mass Spectrom. 2003;14:605–613. doi:10.1016/S1044-0305(03)00201-0.
   PubMed Web of Science ®Google Scholar
• Pace AL, Wong RL, Zhang YT, Kao YH, Wang YJ. Asparagine deamidation dependence on buffer type, pH, and temperature. J Pharm Sci. 2013;102:1712–1723. doi:10.1002/jps.23529.
   PubMed Web of Science ®Google Scholar
• Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corvaïa N, Ionescu R, Beck A. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem. 2009;392:145–154. doi:10.1016/j.ab.2009.05.043.
   PubMed Web of Science ®Google Scholar
• Khawli LA, Goswami S, Hutchinson R, Kwong ZW, Yang J, Wang X, Yao Z, Sreedhara A, Cano T, Tesar D, et al. Charge variants in IgG1: isolation, characterization, in vitro binding properties and pharmacokinetics in rats. MAbs. 2010;613–624. doi:10.4161/mabs.2.6.13333.
   PubMed Web of Science ®Google Scholar
• Leblanc Y, Ramon C, Bihoreau N, Chevreux G. Charge variants characterization of a monoclonal antibody by ion exchange chromatography coupled on-line to native mass spectrometry: case study after a long-term storage at +5 degrees C. J Chromatogr B Analyt Technol Biomed Life Sci. 2017;1048:130–139. doi:10.1016/j.jchromb.2017.02.017.
   PubMed Web of Science ®Google Scholar
• Yin S, Pastuskovas CV, Khawli LA, Stults JT. Characterization of therapeutic monoclonal antibodies reveals differences between in vitro and in vivo time-course studies. Pharm Res. 2013;30:167–178. doi:10.1007/s11095-012-0860-z.
   PubMed Web of Science ®Google Scholar
• Du Y, Walsh A, Ehrick R, Xu W, May K, Liu H. Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies. MAbs. 2012;578–585. doi:10.4161/mabs.21328.
   PubMedGoogle Scholar
• Higel F, Seidl A, Sörgel F, Friess W. N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins. Eur J Pharmaceutics Biopharmaceutics. 2016;100:94–100. doi:10.1016/j.ejpb.2016.01.005.
   PubMed Web of Science ®Google Scholar
• Sinha S, Pipes G, Topp EM, Bondarenko PV, Treuheit MJ, Gadgil HS. Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs. J Am Soc Mass Spectrom. 2008;19:1643–1654. doi:10.1016/j.jasms.2008.07.004.
   PubMed Web of Science ®Google Scholar
• Alpert AJ, Regnier FE. Preparation of a porous microparticulatee anion-exchange chromatography support for proteins. J Chromatogr. 1979;185:375–392. doi:10.1016/S0021-9673(00)85615-0.
   Web of Science ®Google Scholar
• Kozlowski LP. IPC – isoelectric point calculator. Biology Direct. 2016;11:55. doi:10.1186/s13062-016-0159-9.
   PubMed Web of Science ®Google Scholar